Evaluation of postoperative analgesic effect of ultrasound-guided pudendal nerve block after penile lengthening surgery

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400079924

Enrollment

Unknown

Registered

2024-01-16

Start date

2024-02-12

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Concealed Penis

Interventions

Test group:Implement pudendal nerve block

Control group:Without pudendal nerve block

Eligibility

Sex/Gender

Male

Age

14 Years to 35 Years

Inclusion criteria

Inclusion criteria: Patients aged 14 to 35 years, ASA? or ?, who proposed penis lengthening

Exclusion criteria

Exclusion criteria: There is a history of local anesthetic allergy, hemorrhagic disease, coagulation dysfunction, and injection site infection

Design outcomes

Primary

Measure	Time frame
pain;	—

Secondary

Measure	Time frame
The number of times flurbiprofen ester was used;Associated bladder discomfort caused by indwelling catheters;Local anesthetic poisoning;Puncture site hematoma, infection;Incidence of nausea and vomiting;	—

Countries

China

Contacts

Public ContactDing Yongbo

Yantai Yuhuangding Hospital

dybyt@163.com+86 135 6252 8882

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026